Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2025)

Cellebrite DI's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $37.0 million for Q4 2025.

• On a quarterly basis, Other Operating Expenses rose 4.08% year-over-year to $37.0 million in Q4 2025; TTM through Dec 2025 was $153.1 million, a 15.81% increase from a year earlier, with the FY2025 full-year figure at $110.1 million, down 11.89% from the prior year.
• Other Operating Expenses retreated to $37.0 million in Q4 2025 per CLBT's latest filing, from $38.6 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $38.8 million in Q1 2025 and bottomed at $16.5 million in Q1 2021.
• The 5-year median for Other Operating Expenses is $27.6 million (2023), against an average of $28.3 million.
• Across the five-year window, Other Operating Expenses soared 40.62% in 2022 and fell 1.47% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at $20.1 million in 2021, then surged by 40.62% to $28.2 million in 2022, then declined by 1.47% to $27.8 million in 2023, then climbed by 27.79% to $35.5 million in 2024, then grew by 4.08% to $37.0 million in 2025.
• Per Business Quant, the three latest CLBT Other Operating Expenses figures stand at $37.0 million (Q4 2025), $38.6 million (Q3 2025), and $38.7 million (Q2 2025).